Results 201 to 210 of about 10,538,494 (333)

Predictability of the postoperative course of Crohn's disease.

open access: yesGastroenterology, 1990
P. Rutgeerts   +5 more
semanticscholar   +1 more source

Not all weight loss is psychiatric: Diagnostic bias in pediatric Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can often be misdiagnosed, particularly in the female population. This is especially true in the initial stages, which are frequently characterized by weight loss and, at times, dietary intake restriction.
Karolina Aleksandra Jamrozik   +7 more
wiley   +1 more source

Diagnostic Accuracy of Salivary Periodontal Biomarkers Is Reduced in Patients With Crohn's Disease. [PDF]

open access: yesClin Exp Dent Res
Toivanen A   +6 more
europepmc   +1 more source

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

open access: yesJPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri   +4 more
wiley   +1 more source

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

open access: yesGastroenterology, 2006
S. Hanauer   +8 more
semanticscholar   +1 more source

Pathomechanism, diagnosis and surgical management of Crohn's disease

open access: yes, 2018
Crohn’s disease, a chronic inflammatory bowel disease with a relapsing-remitting course, has become an increasing burden in recent years and the incidence and prevalence of this idiopathic disease is continually escalating worldwide.
Ramrekha, Diksha
core  

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

Stricturing Phenotype Predisposes to Small Bowel and Colorectal Malignancy in Crohn's Disease. [PDF]

open access: yesJGH Open
Kanjamala KJ   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy